Case report: development of Hodgkin's disease in patient receiving long-term administration of dacarbazine and interleukin-2 for metastatic melanoma

J Natl Cancer Inst. 1990 Aug 15;82(16):1360. doi: 10.1093/jnci/82.16.1360.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Combined Modality Therapy
  • Dacarbazine / adverse effects*
  • Dacarbazine / therapeutic use
  • Female
  • Hodgkin Disease / chemically induced*
  • Humans
  • Interleukin-2 / adverse effects*
  • Interleukin-2 / therapeutic use
  • Melanoma / drug therapy*
  • Melanoma / secondary
  • Middle Aged

Substances

  • Interleukin-2
  • Dacarbazine